Clinical Trial Update: Study of Individualized Amonafide to Treat Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating individualized amonafide to treat prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Amonafide (amonafide)

Snippet

Sponsor: Xanthus Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED